Boston Scientific Loses Patent Trial
55879
A jury in Texas has ruled that Boston Scientificâs drug-coated stents infringed a 1997 patent issued to a radiologist and has awarded the inventor $431 million.
752
Sun has lost the case brought against it by Eastman Kodak. The photographic giant convinced a Federal jury that Sun infringed its patents in the development of the Java programming language.
197192
ABB Ltd., the Swiss-Swedish electrical engineering giant, said Thursday it had lost its bid to have a U.S. appeals court partially review its $1.2 billion asbestos-claims settlement.
700842
A federal judge has ruled that some  product liability claims against Boston Scientific Corp.   over heart defibrillators can proceed, rejecting the  medical device company&#39;s motions to dismiss them.
767331
Biopharma firm ends trials for a promising drug and offloads four commercial products.
658871
Boston Scientific Corp. , the medical device maker, eliminated 55 jobs in Marlborough last month, according to the state Executive Office of Labor and Workforce Development. Company spokesman Paul Donovan said the Natick firm made the cuts after deciding to pull the plug on its Endovations program, an effort to develop a new single-use endoscope with an integrated ...
436386
One of Forest Labs' Alzheimer's drugs fails in Phase III trials.
347553
A federal appeals court handed Google Inc a setback in a patent fight on Wednesday, tossing out part of a summary judgment in the Web search engine's favor in a lawsuit filed by Hyperphrase Technologies, LLC.
242397
Boston Scientific Corp. said yesterday it has won back the market share that its flagship cardiac stent system held before three safety recalls reduced doctors' orders of the product.
717795
A federal appeals court handed Google a setback in a patent fight on Wednesday, tossing out part of a summary judgment in Google's favor in a lawsuit filed by Hyperphrase Technologies, LLC.
132632
The Food and Drug Administration is unlikely to sanction Boston Scientific Corp. after reviewing its handling of safety recalls of its new cardiac stent system, an agency official said yesterday.
455142
A federal judge has ruled that some product-liability claims against Boston Scientific Corp.  over implantable heart defibrillators can proceed, rejecting the medical device maker's motions to dismiss them.
287954
A United States appeals court upheld a finding of patent infringement against Research In Motion Ltd. yesterday, but struck down part of the ruling and sent it back to a lower court for further proceedings.
243896
Boston Scientific Corp. has reserved another $101 million to defend itself against lawsuits over defibrillators made by Guidant Corp., the heart-device maker it acquired for $27 billion last year. The Natick medical-device company has set aside $485 million to pay for legal costs related to Guidant, it said in a filing this week, up from $384 million in ...
665437
A federal jury awarded $400 million in punitive damages Wednesday to a doctor who accused a medical technology company of infringing on his patents for a surgical device to treat spinal injuries.
695576
Eli Lilly loses a pair of patent cases over its top compound.
550945
The catheter that triggered three safety recalls by Boston Scientific Corp. of its best-selling Taxus coronary stent after being linked to three deaths and 47 injuries had not been subjected to the rigors of a human clinical trial, FDA records show.